in-EV
Extracellular Vesicles
in-EV is a company dedicated to providing researchers with innovative, state-of-the-art tools for studying extracellular vesicles (EVs, including exosomes). in-EV was founded in December 2024 as a subsidiary of Ciloa, a pioneer in EV research and development with over 14 years of experience in the biotechnological development of EVs for the production of a new generation of vaccines and therapeutic vectors.
Product Range:
- Extracellular Vesicles: Standard EVs, labeled (fluorescent or luminescent) EVs, and biotechnologically produced EVs with membrane proteins
- Kits & Products: Kits for the isolation/purification of EVs (from various sources, with varying degrees of purity); kits for the characterization of EVs; DNA for establishing stable cell lines that produce labeled EVs
EastMabBio
High-Quality Recombinant Proteins
Vitro Biopharma
Biotechnology company focused on developing Wharton's jelly-derived cell therapies for autoimmune di...
Norgen Biotek
Sample collection, storage, and isolation of high-purity nucleic acids
KactusBio
Active recombinant proteins and enzymes
Fluorochem
Biochemicals, Bioactive Small Molecules, and Building Blocks